Ulcerative Colitis: Recent Advances in Clinical Management

Dear Colleague,

Therapeutic strategies for inflammatory bowel diseases are rapidly evolving due to the development of a large number of different molecules aimed at specific points of the inflammatory cascade. In many, but not all, instances, therapy is also effective in extraintestinal manifestation, which often impairs the quality of life of ulcerative colitis patients.

The clinical scenario is rapidly changing, and new information is expanding at an ever-quickening pace. In parallel, increasing attention has been focused on the role of the diet and nutrition to prevent the development of IBD and improve clinical outcomes. Thus, the choice of the best treatment of individual patients represents a significant challenge for healthcare professionals.

This Special Issue is aimed at extensively exploring the latest advancements in the treatment of ulcerative colitis, critically examining current and emerging therapies as well as dietary and nutritional interventions. It is open for submissions of manuscripts reporting original research, as well as comprehensive reviews of the current state of the art. We hope that it will represent an effective tool for disseminating the latest research on and critical evaluations of therapeutic strategies in ulcerative colitis. Timing is thus central, and we hope to bring the Special Issue online in six months.

We therefore encourage the submission of papers that are within the scope of this Special Issue, requesting that authors send a short abstract or tentative title in advance, to avoid possible overlapping or duplication. The final manuscript is expected in ten to twelve weeks.

Based on your expertise in the field, we think that you could make an excellent contribution. Thank you in advance for your attention.

Dr. Filippo Vernia
Dr. Angelo Viscido
Dr. Latella Giovanni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• ulcerative colitis
• advanced therapies
• nutrition
• extraintestinal manifestations
• surrogate markers of activity